Description: Taj Pharma India is Best Known Manufacturer, Exporter and Supplier Atracurium Besylate Injection USP 10mg/ml from Vapi, Gujarat India. Atracurium Besylate Injection USP is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Taj Pharma India, a leading pharmaceutical company located in Vapi, Gujarat, is a trusted manufacturer and global exporter of Atracurium Besylate Injection USP 10mg/ml. This essential medication is a non-depolarizing muscle relaxant used in combination with general anesthesia during surgeries and to facilitate mechanical ventilation in critical care settings. Renowned for its high purity, consistent potency, and global compliance, Taj Pharma’s Atracurium Besylate Injection is manufactured in WHO-GMP and ISO-certified facilities, ensuring the highest standards of safety and efficacy. The injection is administered intravenously by trained medical professionals and is not recommended for self-use. It is considered safe for patients with kidney disorders and likely safe during breastfeeding, though it should be used with caution in pregnancy. Minor side effects such as skin flushing, injection site pain, or redness may occur. Taj Pharma supplies this product across India, Africa, the Middle East, and Latin America, making it a preferred partner for hospitals, government tenders, and healthcare institutions. The company also offers PCD Pharma franchise opportunities, bulk supply options, and customized packaging. Taj Pharma India is well established Manufacturer, Exporter and Supplier of Atracurium Besylate Injection USP 10mg/ml from Vapi, Gujarat India. Atracurium Besylate Injection USP 10mg/ml is generally administered by a healthcare professional. You should not self-administer Atracurium Besylate Injection USP at home. The dose and duration will depend on what you are taking it for and how well it helps your symptoms.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 239 KB
